NOVNQ — NVN Liquidation Share News
0.000.00%
- $0.02m
- -$4.60m
- $23.68m
Brief: Novan Engages Syneos Health As Commercial Solutions Provider For SB206
Brief: Novan Appoints Tomoko Maeda-Chubachi As Chief Medical Officer
Novan Inc reports results for the quarter ended in June - Earnings Summary
Brief: Novan Reports Second Quarter 2021 Financial Results And Provides Corporate Update
Novan Inc expected to post a loss of 53 cents a share - Earnings Preview
Brief: Novan Announces Last Patient Visit At Week 24 In Phase 3 Trial Of SB206
Novan jumps as Cantor bullish on co's skin infection gel
Brief: Novan Announces Pricing Of $40 Million Public Offering Of Common Stock
Novan drops on $40 mln stock offering
Novan drops on planned stock deal
Novan soars for second session after positive drug study
U.S. STOCKS ON THE MOVE-Chewy, Novan, Cheetah Mobile, GameStop, gold miners
U.S. STOCKS ON THE MOVE-Livent, Novan, Amesite
U.S. STOCKS ON THE MOVE-GameStop, Livent, Vertex, Royal Caribbean, UWM Holdings
Novan Inc: Jumps as skin infection gel meets main goal in late-stage study
Brief: Novan Reports Positive Topline Results From Pivotal Phase 3 Trial Of SB206 In Patients With Molluscum Contagiosum
U.S. STOCKS ON THE MOVE-Tesla, Geo Group, Signet Jewelers, GameStop, gold miners
U.S. STOCKS ON THE MOVE-GameStop, RH, Signet Jewelers, Occidental, Cleveland-Cliffs
Novan Inc: Up on positive data from COVID-19 treatment study in hamsters